Evofem Negotiates Improved Rebate for Hormone-Free “In the Moment” Contraceptive PHEXXI with Medi-Cal

— Medi-Cal serves more than 15.4 million Californians — — 7.4% improvement in Phexxi rebate to take effect July 1, 2024 — SAN DIEGO, March 20, 2024 /PRNewswire/ — Commercial-stage women’s health innovator Evofem Biosciences, Inc. (OTCQB: EVFMD) today announced that it has successfully…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks